| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |